119
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

ATP7B Gene Variant Profile İdentified by NGS in Wilson’s Disease

ORCID Icon, ORCID Icon, &
Pages 891-900 | Received 15 May 2023, Accepted 12 Sep 2023, Published online: 22 Sep 2023

References

  • Bandmann O, Weiss KH, Kaler SG. Wilson’s disease and other neurological copper disorders. Lancet Neurol. 2015;14(1):103–13. doi:10.1016/S1474-4422(14)70190-5.
  • Lu X, Li S, Zhang W, Lin Y, Lu Z, Cai Y, Su X, Shao Y, Liu Z, Sheng H, et al. Assessment of the diagnostic value of serum ceruloplasmin for Wilson’s disease in children. BMC Gastroenterol. 2022;22(1):124. doi:10.1186/s12876-022-02186-0.30397835.
  • Fan SP, Kuo YC, Lee NC, Chien YH, Hwu WL, Huang YH, Lin HI, Tseng TC, Su TH, Tzeng SR, et al. Clinical characteristics, genetic features, and long-term outcome of Wilson’s disease in a Taiwanese population: an 11-year follow-up study. J Mov Disord. 2023;16(2):168–79. doi:10.14802/jmd.22161.
  • Roberts EA. Update on the diagnosis and management of Wilson disease. Curr Gastroenterol Rep. 2018;20(12):56. doi:10.1007/s11894-018-0660-7.
  • Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24. doi:10.1038/gim.2015.30.
  • Medici V, LaSalle JM. Genetics and epigenetic factors of Wilson disease. Ann Transl Med. 2019;7(Suppl 2):S58. doi:10.21037/atm.2019.01.67.
  • Zhang S, Yang W, Li X, Pei P, Dong T, Yang Y, Zhang J. Clinical and genetic characterization of a large cohort of patients with Wilson’s disease in China. Transl Neurodegener. 2022;11(1):13. doi:10.1186/s40035-022-00287-0.
  • Huong NTM, Hoa NPA, Ngoc ND, Mai NTP, Yen PH, Anh HTV, Hoa G, Dien TM. Mutation spectrum of ATP7B gene in pediatric patients with Wilson disease in Vietnam. Mol Genet Metab Rep. 2022;31:100861. doi:10.1016/j.ymgmr.2022.100861.
  • Gomes A, Dedoussis GV. Geographic distribution of ATP7B mutations in Wilson disease. Ann Hum Biol. 2016;43(1):1–8. doi:10.3109/03014460.2015.1051492.
  • Gromadzka G, Bendykowska M, Przybyłkowski A. Wilson’s disease-Genetic puzzles with diagnostic implications. Diagnostics (Basel). 2023;13(7):1287. doi:10.3390/diagnostics13071287.
  • Kerkar N, Rana A. Wilson disease in children. Clin Liver Dis. 2022;26(3):473–88. doi:10.1016/j.cld.2022.03.008.
  • Schilsky ML, Roberts EA, Bronstein JM, Dhawan A, Hamilton JP, Rivard AM, Washington MK, Weiss KH, Zimbrean PC. A multidisciplinary approach to the diagnosis and management of Wilson disease: 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver Diseases. Hepatology. 2022;77(4):1428–55. doi:10.1002/hep.32801.
  • Ferenci P, Stremmel W, Członkowska A, Szalay F, Viveiros A, Stättermayer AF, Bruha R, Houwen R, Pop TL, Stauber R, et al. Age and sex but not ATP7B genotype effectively ınfluence the clinical phenotype of Wilson disease. Hepatology. 2019;69(4):1464–76. doi:10.1002/hep.30280.
  • Zhou D, Jia S, Yi L, Wu Z, Song Y, Zhang B, Li Y, Yang X, Xu A, Li X, et al. Identification of potential modifier genes in Chinese patients with Wilson disease. Metallomics. 2022;14(5):mfac024. doi:10.1093/mtomcs/mfac024.
  • Stapelbroek JM, Bollen CW, van Amstel JK, van Erpecum KJ, van Hattum J, van den Berg LH, Klomp LW, Houwen RH. The H1069Q mutation in ATP7B is associated with late and neurologic presentation in Wilson disease: results of a meta-analysis. J Hepatol. 2004; 41(5):758–63. doi:10.1016/j.jhep.2004.07.017.
  • Majid Z, Abrar G, Laeeq SM, Khan SA, Ismail H, Soomro GB, Mehmood N, Tasneem AA, Hanif FM, Mandhwani R, et al. Clinical characteristics and comparison of different prognostic scores in Wilson’s disease. Euroasian J Hepatogastroenterol. 2022;12(2):69–72. doi:10.5005/jp-journals-10018-1379.
  • Nayagam JS, Jeyaraj R, Foskett P, Dhawan A, Ala A, Joshi D, Bomford A, Thompson RJ. ATP7B genotype and chronic liver disease treatment outcomes in Wilson disease: worse survival with loss-of-function variants. Clin Gastroenterol Hepatol. 2023;21(5):1323–9. doi:10.1016/j.cgh.2022.08.041.
  • Hiz Kurul S, Oktay Y, Töpf A, Szabó NZ, Güngör S, Yaramis A, Sonmezler E, Matalonga L, Yis U, Schon K, et al. High diagnostic rate of trio exome sequencing in consanguineous families with neurogenetic diseases. Brain. 2022;145(4):1507–18. doi:10.1093/brain/awab395.
  • Jardel A, Bonnet C, Frismand-Kryloff S, Ravel JM, Schmitt E, Obadia MA, Delassaux S, Bronner M, Poujois A, Renaud M. Next-generation sequencing: a decisive diagnostic aid for atypical Wilson’s disease. J Neurol. 2022;269(12):6664–6. doi:10.1007/s00415-022-11270-0.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.